Pharmacology
-
Vanderbilt chemist Ben Brown awarded $2.375M to develop nonaddictive painkillers with AI
Avenir Award funding from the National Institute on Drug Abuse recognizes research that represents “the future of addiction science.” Brown’s research is creating an AI-experiment feedback loop that will help optimize painkilling drugs to be less addictive. Read MoreJan 18, 2024
-
Watch now: Lab-to-Table Conversation: Beyond Addiction: Therapeutic Developments and Societal Impact
Join the next Lab-to-Table conversation, “Beyond Addiction: Therapeutic Developments and Societal Impact” on Jan. 24 at 11:30 a.m. CT. Read MoreJan 11, 2024
-
Quanta Magazine: She studies how addiction hijacks learning in the brain
Erin Calipari works to understand how drugs like opioids and cocaine alter learning circuits and neurochemistry in one of the country's epicenters of substance use disorder and addiction. Read MoreDec 14, 2023
-
Vanderbilt Center for Addiction Research joins Discovery Vanderbilt; Calipari appointed director
The Vanderbilt Center for Addiction Research, led by Erin Calipari, advances research to understand how addiction and substance use disorder develops in the brain. VCAR’s goals are to develop new pharmaceutical strategies and to destigmatize addiction as a personal failing. Read MoreDec 14, 2023
-
Potential schizophrenia treatment, discovered at Vanderbilt and being developed by Neumora Therapeutics, entering Phase 1 clinical trial
In just over two years, a Vanderbilt-Neumora collaboration has led to the Phase 1 clinical trial of a treatment for schizophrenia spectrum disorders, which affect 3.7 million adults in the United States. This is the third chemical compound discovered at the Warren Center for Neuroscience Drug Discovery to reach Phase 1 clinical trials. Read MoreDec 4, 2023
-
Vanderbilt scientists make headway in drug development to cure pulmonary arterial hypertension
Biomedical engineer David Merryman and Warren Center for Neuroscience Drug Discovery director Craig Lindsley have developed a new drug that treats PAH, a type of high blood pressure that affects arteries in the lungs and in the heart, without serious neurological side effects. Read MoreSep 13, 2023
-
Lab-to-Table Conversation: ‘Coffee: Where Science Meets Sips’ on Sept. 27
Join “Coffee: Where Science Meets Sips” in the next Lab-to-Table Conversation on Sept. 27. Read MoreSep 13, 2023
-
CTTC Announces the Awardees of the 2023 Master Innovator Recognition Program
Vanderbilt's Center for Technology Transfer and Commercialization named Richard Caprioli, C. David Weaver, Susan Eagle, and Franz Baudenbacher 2023 Master Innovators. The yearly recognition program acknowledges Vanderbilt’s top innovators and entrepreneurs for their contributions to the creation, development, and commercialization of intellectual property. Read MoreSep 5, 2023
-
Vanderbilt researcher wins grant to study risk factors for Alzheimer’s disease, dementia in older LGBTQ+ adults; experts present at Alzheimer’s conference
Experts in research on Alzheimer’s disease and related dementias share their latest findings at the 2023 Alzheimer’s Association International Conference. Nik Lampe, postdoctoral researcher, was awarded a grant to examine the social and medical factors influencing ADRD using data from VUSNAPS. Read MoreAug 31, 2023
-
Basic Sciences names Hodges, Siciliano as Dean’s Faculty Fellows
Emily Hodges, assistant professor of biochemistry, and Cody Siciliano, assistant professor of pharmacology, have been named Dean’s Faculty Fellows of the School of Medicine Basic Sciences. Read MoreAug 21, 2023
-
Vanderbilt mourns loss of renowned clinical pharmacologist Jackson Roberts II, MD
Jackson Roberts II, MD, an internationally known clinical pharmacologist in the Vanderbilt University School of Medicine who helped define the role of lipid peroxidation and oxidative stress in human disease, died May 31 in Nashville. He was 79. Read MoreJun 5, 2023
-
Lab-to-Table Conversation: ‘Social Media and Addiction’ May 9
How is social media creating conversations about addiction and recovery? How is it building broader community? And how is it a complex space to engage with as a person in recovery? The discussion, led by Erin Calipari, will feature psychiatry experts on May 9. Read MoreApr 27, 2023
-
Vanderbilt biochemists join international researchers in discovery of the first new antibiotic for urinary tract infections in more than 20 years
Neil Osheroff and his lab provide foundational research for new Urinary Tract Infection antibiotic. UTIs affect half of all women. Read MoreJan 18, 2023
-
New screening method could pave the way for future cancer drug discoveries
The laboratories of Brian Bachmann and Jonathan Irish have developed a method to discover new small molecules that may kill cancer cells by working through the body’s immune system. Read MoreJan 17, 2023
-
Research Snapshot: Researchers demonstrate that dopamine is involved in novelty-based learning
Vanderbilt researchers in the lab of Erin Calipari, assistant professor of pharmacology and molecular physiology and biophysics, have demonstrated a role for dopamine signaling in novelty-based learning—a finding that could have major impacts on how neurological diseases are treated. Read MoreDec 16, 2022
-
Vanderbilt University, VUMC faculty named Highly Cited Researchers, rank in top 1 percent by citations
Experts from the Institute for Scientific Information identified 13 faculty at Vanderbilt University and Vanderbilt University Medical Center as among the top one percent of cited researchers worldwide. Read MoreDec 6, 2022
-
Lindsley named 2022 fellow of American Society for Pharmacology and Experimental Therapeutics
Craig W. Lindsley, University Distinguished Professor of Pharmacology, Biochemistry and Chemistry, who holds the William K. Warren, Jr. Chair in Medicine, was recently announced as a 2022 fellow of the American Society for Pharmacology and Experimental Therapeutics for his demonstrated excellence and contributions to pharmacology and to the ASPET organization. Read MoreNov 29, 2022
-
Vanderbilt’s Monteggia and Kavalali are awarded the Anna-Monika Prize
Lisa Monteggia, Barlow Family Director of the Vanderbilt Brain Institute and professor of pharmacology, and Ege Kavalali, chair of the Department of Pharmacology and William Stokes Professor of Experimental Therapeutics, have been awarded the first prize by the Anna-Monika Foundation. Read MoreNov 17, 2022
-
Vanderbilt, international collaborators discover treatment to slow neurodegenerative diseases
Warren Center for Neuroscience Drug Discovery lead researchers discover a therapy that may treat memory loss and slow the progression of Alzheimer’s disease. Read MoreNov 15, 2022
-
Lee named 2022 Innovation Fund investigator by The Pew Charitable Trusts
Ethan Lee, professor of cell and developmental biology and pharmacology, has been named a 2022 Innovation Fund investigator by The Pew Charitable Trusts. Read MoreSep 27, 2022